JLN Hospital and Research Centre, Bhilai
Venomous snakebites have not been adequately evaluated in this country, and the management of such bites has always generated debates and discussions. A 5-year analysis of 96 cases of envenomation by snakes of Elapidae family revealed that the majority of the patients belonged to the 15 to 45 year age group. About 75% of the patients were males. Most patients of the study group had neuroparalytic signs and symptoms, which differed from those who had haemolytic manifestations (not undertaken for analysis).
Because there are no clear-cut guidelines to prescribe the quantum of anti-snake venom (ASV), clinical signs were evaluated to evolve criteria. The average number of ASV (polyvalent) vials consumed was 17 and 13 respectively for those under ventilatory support, and those who were unconscious. There were 4 patients who required more than 100 vials of ASV, one patient needing as many as 180 vials to overcome the ventilator and depression of consciousness.
It is hoped that this study will try to pave the way for a more economical and judicious use of ASV.
